BLCO
HEALTHCAREBausch + Lomb Corp
AI Insight
What's Moving BLCO Today?
No stock-specific AI insight has been generated for BLCO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$12.02$18.91
$15.18
Fundamentals
Market Cap$5.3B
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-3.3%
Profit Margin-4.2%
Debt / Equity—
Trading
Volume188K
Avg Volume (10D)—
Shares Outstanding356.5M
BLCO News
23 articles- Emmecell Announces Closing of Strategic FinancingYahoo Finance·Jun 16, 2026
- Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?Yahoo Finance·Jun 10, 2026
- Bausch + Lomb to lay off employees in MissouriMedtechdive·Jun 10, 2026
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineBiopharmadive·Jun 10, 2026
- Bausch + Lomb Dry Eye Launch Highlights Valuation Gap And Growth QuestionsYahoo Finance·Jun 9, 2026
- Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United StatesYahoo Finance·Jun 1, 2026
- Evercore ISI Group Maintains Bausch + Lomb (BLCO) Outperform RecommendationMSN·May 25, 2026
- Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The RestYahoo Finance·May 21, 2026
- Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare ConferenceYahoo Finance·May 21, 2026
- Bausch + Lomb Announces 2026 Annual Meeting of Shareholder ResultsYahoo Finance·May 20, 2026
- BLCO: All proposals voted on were approved, with final results to be filed in a Form 8-KTradingView·May 20, 2026
- 3 Profitable Stocks We’re Skeptical OfYahoo Finance·May 19, 2026
- Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United StatesYahoo Finance·May 19, 2026
- How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA MomentumYahoo Finance·May 17, 2026
- Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This StockYahoo Finance·May 13, 2026
- Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win247 Wall St·May 13, 2026
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance ConferenceYahoo Finance·May 12, 2026
- Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in EuropeYahoo Finance·May 7, 2026
- Bausch + Lomb Announces Second R&D "Teach-in" WebinarYahoo Finance·May 6, 2026
- What Bausch + Lomb (BLCO)'s Upgraded 2026 Outlook and Narrowing Losses Mean For ShareholdersYahoo Finance·May 2, 2026
- Why Bausch Health Companies Was Crawling Higher This WeekMotley Fool·May 1, 2026
- Bausch + Lomb (BLCO) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the StoryThe Motley Fool·Mar 24, 2026
All 23 articles loaded
Price Data
Open$14.86
Previous Close$14.93
Day High$15.27
Day Low$14.86
52 Week High$18.91
52 Week Low$12.02
52-Week Range
$12.02$18.91
$15.18
Fundamentals
Market Cap$5.3B
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-3.3%
Profit Margin-4.2%
Debt / Equity—
Trading
Volume188K
Avg Volume (10D)—
Shares Outstanding356.5M
About Bausch + Lomb Corp
Bausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—